Csii stock report
Cardiovascular Systems Inc is This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Stock Price Forecast. The 5 analysts offering 12-month price forecasts for Cardiovascular Systems Inc have a median target of 53.00, with a high estimate of View live CARDIOVASCULAR SYSTEMS INC DEL chart to track its stock's Why Is Cardiovascular Systems (CSII) Down 10.8% Since Last Earnings Report? In depth view into CSII (Cardiovascular Systems) stock including the latest Why Is Cardiovascular Systems (CSII) Down 10.8% Since Last Earnings Report? Cardiovascular Systems Inc (CSII) SEC Filing 10-K Annual report for the fiscal year ending Net income was $1.5 million, or $0.04 per basic and diluted share 10 Feb 2020 Cardiovascular Systems, Inc. (NASDAQ:CSII) shareholders might be We're pleased to report that Cardiovascular Systems shareholders have Cardiovascular Systems, Inc. (NASDAQ:CSII) reported a loss per share of 10 cents in second-quarter fiscal 2020 against earnings per share of a penny in the
Van Meerten Stock Picks. Jim Van Meerten's Daily Stock Picks highlights stocks you might want to consider for your portfolio, with Jim's editorials about current events and stock market commentary. Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.
Find the latest Cardiovascular Systems, Inc. (CSII) stock quote, history, news and other vital information to help you with your stock trading and investing. CSII | Complete Cardiovascular Systems Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview. Stock analysis for Cardiovascular Systems Inc (CSII:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company Cardiovascular Systems, Inc. Common Stock (CSII) Stock Quotes - Nasdaq offers Cardiovascular Systems, Inc. Reports Fiscal 2020 Second-Quarter Financial Find the latest Earnings Report Date for Cardiovascular Systems, Inc. Common Stock (CSII) at Nasdaq.com. CSII: Get the latest Cardiovascular Systems stock price and detailed Why Is Cardiovascular Systems (CSII) Down 10.8% Since Last Earnings Report? Research Reports for CSII. All Zacks' Analyst Reports. News for CSII. Zacks News for CSII; Other News for CSII
Stock Price Forecast. The 5 analysts offering 12-month price forecasts for Cardiovascular Systems Inc have a median target of 53.00, with a high estimate of
Cardiovascular Systems Inc (CSII) 10K Annual Reports & 10Q ... Aug 22, 2019 · The following information was filed by Cardiovascular Systems Inc (CSII) on Tuesday, August 6, 2019 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. Quarterly Report (10-q) - Investors Hub CSII Cardiovascular Systems Inc Quarterly Report (10-q) Cardiovascular Systems, Inc. (the “Company” or “CSI ® ”) develops, manufactures and markets devices for the treatment of vascular diseases. The Company’s peripheral arterial disease (“PAD”) products, the Diamondback 360 ® Peripheral Orbital Atherectomy System (“OAS”) and the Stealth 360 ® Peripheral OAS, are catheter CSII Cardiovascular Systems, Inc. Stock Quote Cardiovascular Systems, Inc., a medical device company, develops, manufactures, and commercializes various devices to treat vascular and coronary diseases in the United States.
Mar 31, 2020 · Stock quote and company snapshot for CARDIOVASCULAR SYSTEMS INC (CSII), including profile, stock chart, recent news and events, analyst opinions, and research reports.
csii-20200205 0001180145false00011801452020-02-052020-02-05 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2020 CARDIOVASCULAR SYSTEMS, INC. Cardiovascular Systems, Inc. (CSII) stock price, quote ...
Cardiovascular Systems, Inc. is a company in the U.S. stock market and it is a holding in 59 U.S.-traded ETFs. CSII has around 5.4M shares in the U.S. ETF market.
Cardiovascular Systems Inc (CSII) SEC Filing 10-K Annual report for the fiscal year ending Net income was $1.5 million, or $0.04 per basic and diluted share 10 Feb 2020 Cardiovascular Systems, Inc. (NASDAQ:CSII) shareholders might be We're pleased to report that Cardiovascular Systems shareholders have Cardiovascular Systems, Inc. (NASDAQ:CSII) reported a loss per share of 10 cents in second-quarter fiscal 2020 against earnings per share of a penny in the 18 Mar 2020 The recent performance of RPC (NYSE:RES) stock in the market spoke revenues decreased by -795.50% since the previous quarterly report.
Nov 08, 2019 · CSII, Cardiovascular Systems - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines CSII | Stock Snapshot - Fidelity